Home › Funds › PLATINUM INVESTMENT MANAGEMENT LTD › DRUG

PLATINUM INVESTMENT MANAGEMENT LTD position in DRUG

BRIGHT MINDS BIOSCIENCES INC · Health Care

PLATINUM INVESTMENT MANAGEMENT LTD reported holding 19,127 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$953K, representing 0.49% of its reported portfolio and ranking #49 among its reported holdings. PLATINUM INVESTMENT MANAGEMENT LTD has disclosed DRUG holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)19.13K sh
Reported value held$952.91K
Portfolio Weight0.49%
First reportedQ1 2025
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PLATINUM INVESTMENT MANAGEMENT LTD's DRUG position evolved

PLATINUM INVESTMENT MANAGEMENT LTD first disclosed a stake in DRUG in Q1 2025 at 28,308 shares (US$1.0M). The position peaked in Q3 2025 at 28,308 shares, worth US$1.7M. Across 7 filings, PLATINUM INVESTMENT MANAGEMENT LTD increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 19,127 shares valued at US$953K.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 28.31K $1.02M New
Q2 2025 28.31K $739.12K Hold
Q3 2025 28.31K $1.72M Hold
Q4 2025 21.73K $1.70M Reduce
Q1 2026 19.13K $1.40M Reduce
Q2 2026 19.13K $1.34M Hold
Q3 2026 19.13K $952.91K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DRUG and 13F data

DRUG (BRIGHT MINDS BIOSCIENCES INC) is a Health Care company. 64 other funds we track also report a position in DRUG — the largest reported positions include Cormorant Asset Management, LP (US$63.2M), Vestal Point Capital, LP (US$38.3M), BRAIDWELL LP (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRUG

All DRUG fund holders →

FAQ

How long has PLATINUM INVESTMENT MANAGEMENT LTD held DRUG?

PLATINUM INVESTMENT MANAGEMENT LTD has disclosed DRUG holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is PLATINUM INVESTMENT MANAGEMENT LTD's current position in DRUG?

As of Q3 2026, PLATINUM INVESTMENT MANAGEMENT LTD holds 19.13K shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), valued at $952.91K, representing 0.49% of its reported portfolio and ranking #49.

Has PLATINUM INVESTMENT MANAGEMENT LTD been buying or selling DRUG?

In the latest 13F filing (Q3 2026), PLATINUM INVESTMENT MANAGEMENT LTD held unchanged its position in DRUG. The position peaked in Q3 2025 at 28.31K shares.

Which other funds hold DRUG?

Other major institutional holders of DRUG include Cormorant Asset Management, LP, Vestal Point Capital, LP, BRAIDWELL LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.